title: Interconversion between haloperidol and reduced haloperidol in healthy volunteers.
abstract: The interconversion between haloperidol (HAL) and reduced haloperidol (RHAL) was examined following their separate administration in low (5 mg) single oral doses to 15 young healthy male volunteers in a crossover design. Using an ultrasensitive HPLC method plasma concentrations of HAL and RHAL were monitored over a period of one week following each administration. Except in one case, both the analytes were found in the plasma of all the volunteers following each administration, thereby indicating interconversion of the two compounds. Comparison of the AUC(0-t) ratios of RHAL/HAL and HAL/RHAL following administration of HAL and RHAL, respectively, revealed that the interconversion favours the reduction of HAL to RHAL. The disposition of HAL following administration of RHAL appears to be limited by its rate of formation and the disposition of RHAL following administration of HAL, on the other hand, is much slower than that of the parent compound.
authors.affiliation: College of Pharmacy, University of Saskatchewan, Saskatoon, Canada.
authors.forename: B S
authors.initials: BS
authors.lastname: Chakraborty
authors.forename: J W
authors.initials: JW
authors.lastname: Hubbard
authors.forename: E M
authors.initials: EM
authors.lastname: Hawes
authors.forename: G
authors.initials: G
authors.lastname: McKay
authors.forename: J K
authors.initials: JK
authors.lastname: Cooper
authors.forename: T
authors.initials: T
authors.lastname: Gurnsey
authors.forename: E D
authors.initials: ED
authors.lastname: Korchinski
authors.forename: K K
authors.initials: KK
authors.lastname: Midha
mesh_terms: D000328:Adult; D001711:Biotransformation; D006220:Haloperidol / Q000097:blood / Q000378:metabolism* / Q000493:pharmacokinetics; D006801:Humans; D008297:Male; D010084:Oxidation-Reduction
chemical_list: D006220:Haloperidol